01 October 2005
Serum eosinophil cationic protein and CD23 in acute RSV bronchiolitis.
Kostas N Priftis, Athina Papadopoulou, Emmanuel Liatsis, Dimitrios Katsikas, Polyxeni Nicolaidou, Maria KanariouMed Sci Monit 2005; 11(10): CR493-497 :: ID: 430311
Abstract
BACKGROUND: Elevated concentrations of eosinophil cationic protein (ECP)have been found in acute viral wheezing during infancy. Furthermore, RSV infection has been suggestedto stimulate type-2 cytokine responses. The aim of this study was to test whether serum ECP and solubleCD23 levels, which are markers of eosinophil and IgE responses, respectively, are elevated in infantshospitalized for acute respiratory syncytial virus (RSV) bronchiolitis. MATERIAL/METHODS: Fifty-fiveinfants aged 1-12 months (median: 4.2 months) consecutively hospitalized for acute bronchiolitis weredivided into two groups: RSV-positive (n=26) and RSV-negative patients (n=29). Serum ECP (s-ECP), solubleCD23 (sCD23), and total IgE were measured in all patients and in 23 asymptomatic infants (controls).RESULTS: Lower s-ECP levels were detected in the RSV-positive group (5.4+/-4.3 ng/dl) compared with controls(9.38+/-5.95 ng/dl, p=0.02), but they did not differ significantly from the values of RSV-negative patients(7.8+/-5.7 ng/dl). There was a trend to higher s-ECP values in patients with a positive family historyof atopy and/or a history of atopic dermatitis in the RSV-positive group (p=0.06). No differences insCD23 and total IgE levels among the groups were detected. No correlation between total IgE and sCD23values was observed. CONCLUSIONS: There is no evidence from our data to suggest that either RSV-positiveor RSV-negative acute bronchiolitis is associated with significant eosinophil-mediated degranulation.There is no evidence from the sCD23 data to support the hypothesis that IgE antibody responses are prominentduring the acute illness.
Keywords: Eosinophil Cationic Protein - blood, Bronchiolitis, Viral - virology, Receptors, IgE - blood, Respiratory Syncytial Virus Infections - virology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952